In Loving Memory of Petra Smeltzer Starke
With broken hearts, we share that our beloved wife and mother, Petra, passed away peacefully on February 6, 2026, surrounded by love.
https://t.co/fVdiAck3Yx
I’m Petra’s husband. She’s been fighting cancer for nearly 5 years and is now bedridden. We have a 14-year-old son who needs his mom.
Her next step is specialized/experimental treatment not covered by insurance. Please donate or share: https://t.co/OcBKVeFY0w
My wife, Petra Smeltzer Starke, is battling cancer. She had a first-class ticket, wheelchair assistance, and all documents. Yet @united left her stranded in Cabo without her medicine or chair. She ended up in a hospital instead of her cancer treatment in NY.
Her story: https://t.co/HXZoW1p0jH
@Commanders@JoeJacoby66HOG Happy Birthday to my brother in the trenches, the one and only @JoeJacoby66HOG! 🐷
From day one, you brought grit, power, and heart to every snap.
It was an honor to line up beside you.
Enjoy your day, big man — you’ve earned every bit of the legend. 💪🎂
– George Starke #HOGS
I’m beyond excited to share some incredible progress on our journey with Mainz Biomed! The ongoing clinical trials for ColoAlert®️ are moving ahead faster than expected, bringing us closer to expanding access to this life-saving screening technology.
Why This Matters:
Every accelerated step brings us closer to wider adoption and the ultimate goal of 100% accuracy in early colorectal cancer detection. Early detection can change everything, and this progress gives us even more confidence that we’re on the right path to making it the new standard.
But we’re not stopping there.
💡 What’s Next?
BIG announcements are on the way, including a new partnership that’s set to redefine accessibility, innovation, and reach. This is about scaling up and ensuring that more people worldwide have access to accurate, non-invasive colorectal cancer screening. 🌍
For me, this isn’t just about clinical milestones. It’s about saving lives. Too many people miss out on early detection due to outdated screening methods or simply not knowing how critical it is to get tested.
That’s why Mainz Biomed is pushing harder than ever to bring this revolutionary screening into more hands—and homes.
Faster trials. Greater access. Fewer missed cases. More lives saved.
This is critical. This is progress. And this is just the beginning. 💙
#MainzBiomed #MYNZ #ColorectalCancer #QuestDiagnostics #ThermoFisher #ClinicalTrials #Cancer #CRC #EarlyDetection #Innovation
This journey has been filled with challenges, breakthroughs, and moments of true innovation. The launch of our enhanced DNA stabilizing buffer was a major step forward, increasing accuracy and proving what’s possible when we push the boundaries of early detection. But here’s what excites me the most—we’re not stopping there.
We are working on something new, something that could once again change everything we know about early detection. The science behind it? Groundbreaking. The potential impact? Unpredictable. This is more than just another product—it’s a shift in how we think about preventing cancer before it starts.
I can’t say much yet, but what I can tell you is this: it’s coming, and it’s going to be big.
Stay tuned. 💙🔬
#MainzBiomed #EarlyDetection #Innovation #TheNextBreakthrough #GameChanger #NewProduct
@MainzBioMed@TheHeadHog